Cargando…

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature

Detalles Bibliográficos
Autores principales:	Apel, Anja, Iliev, Daniel I., Urban, Christina, Weber, Karin, Schweizer, Roland, Blumenstock, Gunnar, Pasche, Sarah, Nieratschker, Vanessa, Binder, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552536/ https://www.ncbi.nlm.nih.gov/pubmed/36237196 http://dx.doi.org/10.3389/fendo.2022.1020804

Ejemplares similares

GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature
por: Apel, Anja, et al.
Publicado: (2022)

Increase of jump performance during GH treatment in short children born SGA
por: Schweizer, Roland, et al.
Publicado: (2023)

Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study
por: Blankenstein, Oliver, et al.
Publicado: (2017)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

SUN-260 The Severity of GH Deficiency (GHD) Does Not Affect Adherence to Treatment in GHD Prepubertal Children Taking rh-GH via the Easypod Device
por: Loche, Sandro, et al.
Publicado: (2019)

GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism
por: Tauber, M, et al.
Publicado: (2007)

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

Changes, limitations, and prospects of adult height in GH treatment for Japanese GHD patients
por: Tanaka, Toshiaki
Publicado: (2022)

Difficulties in Interpreting IGF-1 Levels in Short Stature Children Born Small for Gestational Age (SGA) Treated with Recombinant Human Growth Hormone (rhGH) Based on Data from Six Clinical Centers in Poland
por: Glińska, Marta, et al.
Publicado: (2023)

Response to Treatment with Recombinant Human Growth Hormone (rhGH) of Short Stature Children Born Too Small for Gestational Age (SGA) in Selected Centres in Poland
por: Glińska, Marta, et al.
Publicado: (2022)

Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH
por: Miller, Bradley S, et al.
Publicado: (2023)

RF13 | PMON59 Tracking and Cumulative Lifetime Exposure to Circulating IGF-I in 6,459 Healthy Individuals and in SGA Children Treated with GH
por: Kjaer, Anna Sophie Lebech, et al.
Publicado: (2022)

Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
por: Sävendahl, Lars, et al.
Publicado: (2021)

Correction to: “Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH”
Publicado: (2023)

Discrepancies between Physician and Parent Perceptions of Psychosocial Problems of GHD Children Undergoing GH Therapy in Japan
por: Arisaka, Osamu, et al.
Publicado: (2006)

Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center
por: Al Shaikh, Adnan, et al.
Publicado: (2020)

Stratifying the Genetic Aetiology in Children Born Small for Gestational Age With Persistent Short Stature (SGA-SS)
por: Toni, Ledjona, et al.
Publicado: (2021)

IGF1R Gene Alterations in Small for Gestational Age (SGA) Children
por: Janchevska, Aleksandra, et al.
Publicado: (2018)

Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
por: Devesa, Jesús, et al.
Publicado: (2011)

Effects of Growth Hormone (GH) Supplementation on Dermatoscopic Evolution of Pigmentary Lesions in Children with Growth Hormone Deficiency (GHD)
por: Panarese, Fabrizio, et al.
Publicado: (2022)

Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

Turner syndrome presented with tall stature due to overdosage of the SHOX gene
por: Seo, Go Hun, et al.
Publicado: (2015)

IGF1R Gene Alterations in Children Born Small for Gestitional Age (SGA)
por: Janchevska, Aleksandra, et al.
Publicado: (2018)

Growth Outcome and Metabolic Profile of PWS Patients Treated With GH and Differences Between AGA and SGA Group
por: Yoon, Ju Young, et al.
Publicado: (2021)

Evolving pituitary hormone deficits in primarily isolated GHD: a review and experts’ consensus
por: Binder, Gerhard, et al.
Publicado: (2020)

The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis
por: Verhelst, Johan, et al.
Publicado: (2018)

Ghd8 controls rice photoperiod sensitivity by forming a complex that interacts with Ghd7
por: Wang, Peng, et al.
Publicado: (2019)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency
por: Perez-Colon, Sheila, et al.
Publicado: (2018)

Therapeutic Efficacy and Safety of GH in Japanese Children with Down Syndrome Short Stature Accompanied by GH Deficiency
por: Meguri, Kyoko, et al.
Publicado: (2013)

Comparative Sequence Analysis of the Ghd7 Orthologous Regions Revealed Movement of Ghd7 in the Grass Genomes
por: Yang, Lu, et al.
Publicado: (2012)

The Auxological and Biochemical Continuum of Short Children Born Small for Gestational Age (SGA) or with Normal Birth Size (Idiopathic Short Stature)
por: Caliebe, Janina, et al.
Publicado: (2010)

Do IGF-I concentrations better reflect growth hormone (GH) action in children with short stature than the results of GH stimulating tests? Evidence from the simultaneous assessment of thyroid function
por: Smyczyńska, Joanna, et al.
Publicado: (2011)

Effects of GH/IGF on the Aging Mitochondria
por: Poudel, Sher Bahadur, et al.
Publicado: (2020)

The Multiple Faces of the GH/IGF Axis
por: Chesnokova, Vera
Publicado: (2022)

A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome
por: Clayton, P, et al.
Publicado: (2013)

Evaluation of Permanent Growth Hormone Deficiency (GHD) in Young Adults with Childhood Onset GHD: A multicenter study
por: Berberoğlu, Merih, et al.
Publicado: (2008)

Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: Li, Juan, et al.
Publicado: (2021)

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome
por: Stevens, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ugp8gquarpt5tjf7l5v738rkdd